Dentistry

SHERIDAN, WYOMING - May 1, 2025 - KaVo, a global leader in dental technology, has announced a major expansion of its digital imaging portfolio with the introduction of several new ProXam solutions, strengthening its presence in both intraoral and extraoral diagnostics. This strategic move is set to offer dental professionals greater clarity, flexibility, and precision across all diagnostic applications, driving clinical accuracy and operational efficiency.

Expanded ProXam Line Brings Comprehensive Imaging Capabilities

With this announcement, KaVo reinforces its commitment to providing a complete digital diagnostics solution through the ProXam portfolio. The new additions include:

SHERIDAN, WYOMING – May 1, 2025 – Planmeca, a global leader in dental imaging and technology, has officially announced the launch of its first-ever handheld intraoral X-ray device, the Planmeca ProX™ GO. Designed for optimal portability, efficiency, and image quality, the new device aims to transform diagnostic workflows in both traditional dental clinics and mobile care environments. The product will make its debut at IDS 2025 in Cologne, with an initial sales rollout planned for the U.S. market.

A Leap Toward Portable Imaging Solutions

SHERIDAN, WYOMING – May 1, 2025 – Danaher Corporation (NYSE: DHR), a global science and technology leader, reported first-quarter 2025 financial results that exceeded expectations across revenue, earnings, and cash flow, underscoring the strength of its diversified portfolio and operational excellence amid a dynamic macroeconomic environment.

Total revenue for the quarter reached $5.7 billion, reflecting a modest 1.0% year-over-year decline. However, non-GAAP core revenue remained flat compared to Q1 2024, signaling underlying stability. Net earnings stood at $1.0 billion, or $1.32 per diluted share, while adjusted diluted net earnings per share reached $1.88. Free cash flow for the quarter totaled $1.1 billion, reinforcing Danaher’s strong cash generation capabilities.

Strong Segment Performance and Resilience in Diagnostics

SHERIDAN, WYOMING – May 1, 2025 – Henry Schein, Inc. (Nasdaq: HSIC), a global leader in health care solutions for office-based practitioners, has been selected by Health Future, a healthcare consortium owned by Oregon-based hospitals and systems, as the exclusive supplier of disposable skin staplers and staple removers for its network of 22 care facilities. The agreement reflects a shared commitment to improving procurement efficiency, standardizing clinical practices, and optimizing patient outcomes across the consortium’s operations.

Enhancing Clinical and Operational Efficiency

SHERIDAN, WYOMING – May 1, 2025 – Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC), has named Ian Jeffer, MS, ATC, LAT, Head Athletic Trainer at Desert Ridge High School in Mesa, Arizona, as the winner of its fifth annual Athletics and Schools Rising Star Award. The announcement recognizes Jeffer's exceptional contributions to student-athlete care, his leadership in developing future athletic trainers, and his broader impact on the Gilbert Public Schools District.

Spotlighting Emerging Leadership in Athletic Training

Created to honor athletic trainers with fewer than five years of experience, the Rising Star Award is designed to showcase professionals on a strong upward career trajectory. The award reflects Henry Schein Medical’s ongoing commitment to fostering talent that enhances community health outcomes and raises the bar in sports medicine education and practice.

SHERIDAN, WYOMING – May 1, 2025 – Align Technology, Inc. (Nasdaq: ALGN), a global leader in digital orthodontics and restorative dentistry, announced its executive team will present at three major financial conferences in May and June 2025. These appearances will underscore the company’s continued market leadership and long-term strategic focus on innovation, digital transformation, and global expansion in the healthcare technology sector.

Leadership Engagement Reflects Strategic Momentum

Executives from Align Technology will share insights into the company’s operational performance, growth strategy, and market opportunities across three prominent investor events:

SHERIDAN, WYOMING – May 1, 2025 – Align Technology, Inc. (Nasdaq: ALGN), a global leader in clear aligner therapy and digital orthodontics, has officially launched the Invisalign® System with mandibular advancement featuring occlusal blocks (MAOB) in the United States and Canada. Unveiled at the 2025 American Association of Orthodontists (AAO) Annual Session in Philadelphia, this strategic release enhances Align’s clinical portfolio for Class II malocclusion, offering practitioners a streamlined, effective solution for growing patients.

A Comprehensive Solution for Class II Skeletal Correction

SHERIDAN, WYOMING – May 1, 2025 – The Straumann Group, a global leader in dental implantology and aesthetic dentistry solutions, has announced a live audio webcast to present its financial results for the first quarter of 2025. The webcast, scheduled for Wednesday, April 30, 2025, from 10:30 to 11:30 a.m. CEST, is designed for investors, financial analysts, and media representatives seeking timely insights into the Group’s latest performance and strategic direction.

Insight into Q1 2025 Business Performance

Straumann will release its Q1 2025 sales figures earlier the same day, at approximately 07:00 a.m. CEST, across its standard communication channels. This early release aims to provide financial stakeholders with prompt and transparent access to key performance indicators.

SHERIDAN, WYOMING - May 1, 2025 - Straumann Group, a global leader in tooth replacement and orthodontic solutions, has announced the release of its 2025 first-quarter financial results, which will be shared in a live audio webcast held on Wednesday, April 30, from 10:30 to 11:30 a.m. CEST. This timely disclosure underscores Straumann's commitment to transparent investor relations and ongoing market engagement.

The webcast is tailored for investors, financial analysts, and journalists, offering a comprehensive review of the Group's Q1 performance by top management. With a live Q&A segment included, the session will offer valuable insights into the company's operational progress, financial standing, and strategic outlook for 2025.

Investor-Focused Financial Disclosure and Access

SHERIDAN, WYOMING - May 1, 2025 - Straumann Group has delivered a strong start to 2025, reporting CHF 680.7 million in first-quarter sales, with an impressive 11.0% organic growth. Despite a backdrop of ongoing macroeconomic headwinds, the company's performance was driven by robust regional expansion in EMEA and APAC, strategic innovation in digital dentistry, and continued success in both premium and challenger implant segments.

Double-Digit Growth Across Key Markets Strengthens Global Footprint